The fund seeks to invest around the world in large cap companies with above average earnings growth.
The disciplined investment approach looks for companies with competitive advantages, strong balance sheet and generating double-digit earnings growth. The fund also requires companies to generate sustainable return on capital of at least 20% a year.
The concentrated portfolio of high conviction names is managed with portfolio turnover of less than 20%. Fund allocates about 60% its investment in North America, 25% in Europe and 14% in Asia Pacific excluding Japan.
Top 10 holdings in the fund account for about 55% of total assets.
The fund seeks to invest in large cap companies with sustainable above-average earnings growth.
Investment process looks for building high conviction in large cap companies with sustainable competitive advantages, generating high returns on capital and steady but rising earnings.
Investment team builds a concentrated portfolio of high conviction names with long-term holding periods.
The fund seeks to invest in large cap companies around the world outside the United States.
The investment process looks to identify companies that have developed a durable earnings profile, have strong balance sheet and are generating high return of capital.
Portfolio consists of 30 companies with attractive business and financial fundamentals and the companies may remain in fund as long as a decade. Currently fund is invested in high growth companies in clinical research outsourcing, innovative pharmaceutical makers, e-commerce and social networking companies in China.
Fund invests about 65% of its assets in Europe, 25% in Asia outside of Japan and nearly 2% in Africa and Latin America each.
The fund invests in small companies around the world including the United States.
The fundamental research driven investment process looks for companies with durable earnings profile, strong balance sheet and management with a successful track record of reinvestment in business growth. The fund prefers to invest in companies with market cap of less than $5 billion.
The fund allocates about 45% of its investment in Europe, 15% in North America, 15% in Asia Pacific ex Japan, 10% in Latin America and 5% in Japan.
The fund seeks to invest in small cap companies based in the U.S. that are experiencing attractive growth.
Investment process of the fund looks for companies that are generating consistent earnings and growing at above-average rate. Fundamental research driven approach looks for companies generating high free cash flow.
Weighted average market cap in the fund is about $4.4 billion.
